- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
High levels of Vegetable Omega-3 may improve Prognosis in Patients With HF
Researchers have found in a new study that high levels of Vegetable Omega-3 may improve Prognosis in Patients With heart failure. Further the study found that Heart failure patients with bottom 25% alpha-linolenic acid in serum phospholipids had worse prognoses during mid-term follow-up.
The study was published in the Journal of the American College of Cardiology.
Heart failure cases impose a socioeconomic burden and there is a dire need for cost-effective strategies to promote quality of life in patients with heart failure. Previous literature reported the benefits of marine omega-3 fatty acids and plant-based dietary patterns in heart failure prognosis. Hence, researchers conducted a study to explore whether dietary alpha-linolenic acid (ALA), the main plant omega-3, shows a better prognosis in HF. Serum phospholipids reflect long-term dietary ALA intake and their metabolism. ALA was determined in serum phospholipids by gas chromatography in 905 ambulatory patients with HF caused by different etiologies.
Results
- 140 all-cause deaths, 85 cardiovascular (CV) deaths, and 141 first HF hospitalizations (composite of all-cause death and first HF hospitalization, n = 238) were documented after a median follow-up of 2.4 years.
- Compared with patients at the lowest quartile of ALA in serum phospholipids (Q1), those at the 3 upper quartiles (Q2-Q4) exhibited a reduction in the risk of a composite of all-cause death and first HF hospitalization as observed in the Cox regression analysis.
- Statistically significant reductions were observed for all-cause death, CV death, first HF hospitalization, and the composite of CV death and HF hospitalization.
This study throws light on who should be targeted for interventions. Any heart failure patient with the bottom 25% ALA levels in serum phospholipids at a mid-term follow-up will have the worst prognosis. Hence, they should be targeted for testing dietary ALA-rich interventions to promote quality of life.
Further reading: Lázaro I, Lupón J, Cediel G, et al. Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure. J Am Coll Cardiol. 2022;80(18):1751-1758. doi:10.1016/j.jacc.2022.08.771
BDS, MDS
Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751